Profil bibliographique

Carmen Baccarini

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

24Publications signalées

434Citations signalées

1Affiliations récentes

Institutions déclarées

Domaines associés

Bacterial Infections and VaccinesSARS-CoV-2 and COVID-19 ResearchVaccine Coverage and HesitancyVirology and Viral DiseasesCOVID-19 Clinical Research Studies

Publications récentes

Accès ouvert 2025 articleOpenAlex

Immunogenicity and safety of self-amplifying mRNA COVID-19 vaccine (ARCT-2303), with or without co-administration of seasonal inactivated influenza vaccine in adults: a phase 3, randomised, controlled, observer-blind, multicentre study

Michelle Giles, Charissa Fay Corazon B. Tabora, Carmen Baccarini, Javier Cespedes Vargas et autres

8 citationsEClinicalMedicine

Accès ouvert 2025 articleOpenAlex

Safety profile of self-amplifying mRNA SARS-CoV-2 vaccine ARCT-154 in adults: a pooled phase 1/2/3 randomized clinical study

Nhan Thi Ho, Igor Smolenov, Lydia Tran, Van Thu Nguyen et autres

13 citationsExpert Review of Vaccines

Accès ouvert 2023 preprintOpenAlex

Safety and immunogenicity of SCB-2019, an adjuvanted, recombinant SARS-CoV-2 trimeric S-protein subunit COVID-19 vaccine in healthy 12–17 year-old adolescents

Pío López, Lulu Bravo, Erik Buntinx, Charissa Borja-Tabora et autres

0 citationsmedRxiv

Accès ouvert 2023 articleOpenAlex

Six-month safety follow-up of an adjuvanted SARS-CoV-2 trimeric S-protein subunit vaccine (SCB-2019) in adults: A phase 2/3, double-blind, randomized study

Romana Hosain, Peter Aquino, Carmen Baccarini, Igor Smolenov et autres

7 citationsVaccine

Accès ouvert 2023 articleOpenAlex

Immunogenicity of an adjuvanted SARS-CoV-2 trimeric S-protein subunit vaccine (SCB-2019) in SARS-CoV-2-naïve and exposed individuals in a phase 2/3, double-blind, randomized study

Erik Buntinx, L Brochado, Charissa Borja-Tabora, Charles Yu et autres

16 citationsVaccine

Accès ouvert 2023 articleOpenAlex

Safety and immunogenicity of SCB-2019, an adjuvanted, recombinant SARS-CoV-2 trimeric S-protein subunit COVID-19 vaccine in healthy 12–17 year-old adolescents

Pío López, Lulu Bravo, Erik Buntinx, Charissa Borja-Tabora et autres

7 citationsHuman Vaccines & Immunotherapeutics

Accès ouvert 2022 articleOpenAlex

Impact of previous exposure to SARS-CoV-2 and of S-Trimer (SCB-2019) COVID-19 vaccination on the risk of reinfection: a randomised, double-blinded, placebo-controlled, phase 2 and 3 trial

Igor Smolenov, Htay Htay Han, Ping Li, Carmen Baccarini et autres

24 citationsThe Lancet Infectious Diseases

Accès ouvert 2022 articleOpenAlex

Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019: a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial

Lulu Bravo, Igor Smolenov, Htay Htay Han, Ping Li et autres

113 citationsThe Lancet

2021 articleOpenAlex

Safety and Immunogenicity Of A Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) Administered In Healthy Meningococcal Vaccine-Naïve Children (2-9 Years)

Michael Simon, Anne Zomcik, Donald M. Brandon, Shane Christensen et autres

1 citationPEDIATRICS

2021 conference-paperOpenAlex

Safety and Immunogenicity Of A Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) Administered In Healthy Meningococcal Vaccine-Naïve Children (2-9 Years)

Michael Simon, Anne Zomcik, Donald M. Brandon, Shane Christensen et autres

1 citation

Accès ouvert 2020 articleOpenAlex

Safety and Immunogenicity of a Quadrivalent Meningococcal Conjugate Vaccine in Healthy Meningococcal-Naïve Children 2–9 Years of Age: A Phase III, Randomized Study

Carmen Baccarini, Michael Simon, Donald M. Brandon, Shane Christensen et autres

26 citationsThe Pediatric Infectious Disease Journal

Accès ouvert 2019 articleOpenAlex

2724. Safety and Immunogenicity of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) Administered in Healthy Meningococcal Vaccine-Naïve Children (2–9 Years)

Michael Simon, Donald M. Brandon, Shane Christensen, Carmen Baccarini et autres

3 citationsOpen Forum Infectious Diseases

Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.